EvoNext Holdings SA (ELVAF)
Market Closed
10 Aug, 20:00
$
2. 15
0
0%
$
8.15M Market Cap
- P/E Ratio
- Div Yield
160 Volume
0 Eps
$ 2.15
Previous Close Want to track ELVAF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ELVAF closed yesterday higher at $2.15, an increase of 0% from Friday's close, completing a monthly increase of 0% or $0. Over the past 12 months, ELVAF stock gained 95.4545%.
ELVAF is not paying dividends to its shareholders.
The last earnings report, released on Feb 19, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
EvoNext Holdings SA has completed 3 stock splits, with the recent split occurring on Apr 26, 2023.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on SIX (CHF).
EvoNext Holdings SA (ELVAF) FAQ
What is the stock price today?
The current price is $2.15.
On which exchange is it traded?
EvoNext Holdings SA is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is ELVAF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 8.15M.
Has EvoNext Holdings SA ever had a stock split?
EvoNext Holdings SA had 3 splits and the recent split was on Apr 26, 2023.
EvoNext Holdings SA Profile
| Biotechnology Industry | Healthcare Sector | Gerhard Lobmaier CEO | OTC PINK Exchange | CH1262055788 ISIN |
| CH Country | 49 Employees | - Last Dividend | 31 Oct 2017 Last Split | - IPO Date |
Overview
Evolva Holding SA is a pioneering company based in Reinach, Switzerland, with a focus on the discovery, research, development, and commercialization of nature-based ingredients. These ingredients are tailored for a wide range of applications including flavors and fragrances, health ingredients, and health protection, servicing clients not only in Switzerland and the United States but also on an international scale. Since its inception in 2004, Evolva has dedicated itself to harnessing the power of nature through advanced biotechnological methods, offering sustainable and innovative solutions across various industries.
Products and Services
- Veri-te Resveratrol: A natural ingredient created via fermentation, Veri-te Resveratrol is found in grapes, peanuts, cranberries, and other berries. It leverages the health benefits of resveratrol, offering applications in dietary supplements and health products for its antioxidative properties.
- L-Arabinose: Used as a flavoring agent, L-Arabinose is a sugar derived from corn and can contribute to sugar reduction in foods by inhibiting the absorption of sucrose. This makes it particularly valuable for weight management and controlling blood sugar levels.
- Valencene: Originating from the aroma of citrus fruits, Valencene is used in the creation of fragrance and flavor compounds. It delivers a sweet, citrusy odor that is highly sought after in perfumery and food flavoring, capturing the essence of freshness.
- Nootkatone: Obtained through the biochemical oxidation of valencene, Nootkatone is another citrus-scented compound, characterized by its grapefruit aroma. It’s not only used for its scent but also for its pesticidal properties, offering a natural solution for controlling pests.
- Vanillin: As a primary component of vanilla bean extract, synthetic vanillin produced by Evolva provides a sustainable and ethical alternative to natural vanilla. It possesses a rich, warm vanilla flavor used extensively in food and beverage products, as well as in fragrances.
Contact Information
Address: Duggingerstrasse 23
Phone: 41 61 485 2000
Website: https://evonextholdings.com
